SB11-0152 Screening compound: 4-{[4-(morpholine-4-carbonyl)-1H-1,2,3-triazol-1-yl]methyl}-1-(quinoline-2-carbonyl)piperidin-4-ol

SB11-0152 Screening compound: 4-{[4-(morpholine-4-carbonyl)-1H-1,2,3-triazol-1-yl]methyl}-1-(quinoline-2-carbonyl)piperidin-4-ol
SB11-0152 Screening compound: 4-{[4-(morpholine-4-carbonyl)-1H-1,2,3-triazol-1-yl]methyl}-1-(quinoline-2-carbonyl)piperidin-4-ol alternative view

Chemical Structure Depiction of ChemDiv screening compound SB11-0152
4-{[4-(morpholine-4-carbonyl)-1H-1,2,3-triazol-1-yl]methyl}-1-(quinoline-2-carbonyl)piperidin-4-ol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SB11-0152

Molecular Formula

C23H26N6O4 (C23 H26 N6 O4)

Compound Name

4-{[4-(morpholine-4-carbonyl)-1H-1,2,3-triazol-1-yl]methyl}-1-(quinoline-2-carbonyl)piperidin-4-ol

IUPAC name

4-{[4-(morpholine-4-carbonyl)-1H-123-triazol-1-yl]methyl}-1-(quinoline-2-carbonyl)piperidin-4-ol

SMILES

OC(Cn1nnc(C(N2CCOCC2)=O)c1)(CC1)CCN1C(c1nc2ccccc2cc1)=O

InChI

InChI=1S/C23H26N6O4/c30-21(19-6-5-17-3-1-2-4-18(17)24-19)27-9-7-23(32,8-10-27)16-29-15-20(25-26-29)22(31)28-11-13-33-14-12-28/h1-6,15,32H,7-14,16H2

InChI Key

HGPBIFWAIRKZNA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD32246103

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

450.5

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.269

Distribution Coefficient, logD

0.269

Water Solubility, LogSw

-1.83

Polar Surface Area

91.860

Acid Dissociation Constant (pKa)

15.47

Base Dissociation Constant (pKb)

0.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.48

SB11-0152 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with SB11-0152 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SB11-0152?
Check Price and Availability of SB11-0152, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SB11-0152 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SB11-0152
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SB11-0152
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SB11-0152 available by request